654 related articles for article (PubMed ID: 8509066)
21. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
22. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
23. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
24. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
[TBL] [Abstract][Full Text] [Related]
25. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
26. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
[TBL] [Abstract][Full Text] [Related]
27. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
28. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
[TBL] [Abstract][Full Text] [Related]
29. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
30. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
Yamaguchi M; Yamamoto K; Miura O
Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
[TBL] [Abstract][Full Text] [Related]
32. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
33. Chronic myelogenous leukemia molecular signature.
Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T
Oncogene; 2003 Jun; 22(25):3952-63. PubMed ID: 12813469
[TBL] [Abstract][Full Text] [Related]
34. [Detection of FLT3 gene and FLT3/ITD gene mutation in chronic myeloid leukemia and its significance].
Xu B; Tian H; Zhou SY
Ai Zheng; 2004 Oct; 23(10):1218-21. PubMed ID: 15473940
[TBL] [Abstract][Full Text] [Related]
35. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
36. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K
Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
[TBL] [Abstract][Full Text] [Related]
37. BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.
Gonzalez MS; De Brasi CD; Bianchini M; Gargallo P; Moiraghi B; Bengió R; Larripa IB
Blood Cells Mol Dis; 2010 Oct; 45(3):192-6. PubMed ID: 20728382
[TBL] [Abstract][Full Text] [Related]
38. Molecular insights into the Philadelphia translocation.
Heisterkamp N; Groffen J
Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
[TBL] [Abstract][Full Text] [Related]
40. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
